Back to News
Market Impact: 0.3
Novo Nordisk A/S Reports Q3 2026 Adjusted Operating Profit of DKK 31,720 million
Source: Nasdaq
Corporate EarningsHealthcare & BiotechCompany Fundamentals
Novo Nordisk reported adjusted Q3 2026 sales of DKK 79,195 million, up 4% at constant exchange rates. The company attributed growth to continued GLP-1 volume increases across geographies, particularly in obesity.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
NVO0.45
More News
- European shares jump over 1% after Democrats sweep US Congress, Novo Nordisk surges
- Novo CEO Doustdar 'Very Optimistic' About CagriSema
- Novo Nordisk ADR earnings missed by $3.74, revenue fell short of estimates
- Stocks making the biggest moves midday: CoreWeave, Micron, Booking Holdings, McDonald's, CVS Health & more
- European shares gain on Novo’s results; markets weigh U.S. midterms
- Stocks making the biggest moves premarket: Trump Media, Tesla, CoreWeave, Novo Nordisk and more